GI Dynamics today announced the results of a study of its EndoBarrier system that met efficacy and safety endpoints.
Boston-based GI Dynamics designed its EndoBarrier endoscopically delivered device therapy as a non-surgical, alternative treatment for type 2 diabetes and obesity for patients who do not have adequate control of their conditions through their current medication and lifestyle.
